Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures

Withdrawn before enrolling · Not applicable

Conditions studied: Pancreatic Cancer

In brief

The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.

Key facts

Study ID

NCT02366858

Run by

AdventHealth

People needed

0

Starts

2013-10-01

Expected to finish

2015-06-01

Last updated by the study team

2017-02-14

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients who are referred to Florida Hospital Center for Interventional Endoscopy for a EUS FNA for core biopsy (19 gauge needle biopsy) who have needle dysfunction (This occurs in about 10% of patients)

You may not qualify if…

• Age under 19 years
• Pregnant women will be excluded. This will be confirmed by self-report

Where it is running

• Florida Hospital — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.